4tissue develops an injectable hydrogel tissue mimic technology for soft tissue reconstruction and regeneration. This bioresorbable biomaterial supports the body's natural cell growth to create durable, body-own tissue following procedures like mastectomy. The minimally invasive solution aims to provide natural-looking results in a single treatment without synthetic implants.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current breast reconstruction methods, such as implants and flap surgeries, often involve multiple procedures, potential complications, and unnatural results. Low cell survival rates in cell-based therapies further limit the effectiveness and predictability of these procedures.
Solution
4Tissue is developing a bioresorbable hydrogel tissue mimic technology designed to enhance natural cell regeneration for breast reconstruction. This minimally invasive, injectable solution supports the body's own tissue regeneration process, leading to durable and predictable results. The hydrogel protects and anchors cells, providing a nurturing environment and supporting natural blood vessel growth to supply essential nutrients. As the hydrogel resorbs, it leaves healthy, natural tissue, offering a safer and more natural-looking alternative to traditional methods.
Target Audience
The primary target audience includes women undergoing mastectomy who are seeking safer, more effective, and natural breast reconstruction treatments, as well as plastic and reconstructive surgeons.
Features
- Bioresorbable hydrogel that mimics natural tissue
- Minimally invasive injection procedure, resulting in minimal to no visible scarring
- Supports natural cell regeneration for durable, body-own tissue formation
- Protects and anchors cells, promoting cell survival and growth
- Supports natural blood vessel growth to supply essential nutrients
- Bio-compatible material that minimizes risks of rejection and complications